Author Interviews, Cancer Research, JAMA, MRI, Prostate Cancer / 07.08.2019
MRIs Improve Targeting of Biopsies for Prostate Cancer Diagnosis
MedicalResearch.com Interview with:
Dr Martha Elwenspoek PhD
Research Associate in Epidemiology and Health Services Research
NIHR CLAHRC West,
Bristol
MedicalResearch.com: What is the background for this study?
Response: Prostate cancer is one of the most common cancers in men. Prostate cancer is usually diagnosed by taking 10 to 14 systematic samples from the prostate guided by ultrasound. However, these biopsies are unpleasant for patients, can miss cancer even when it’s present, can misclassify the severity of the cancer, and can cause side effects, such as bleeding and infection.
If biopsies could be targeted better, men wouldn’t have to undergo so many and there would be less risk of getting a misleading result. Multiparametric MRI (mpMRI) scans are sometimes used before doing a biopsy to help diagnose prostate cancer, and while this approach is now being recommended by the UK National Institute for Clinical Excellence (NICE) their use isn’t widespread.
(more…)